A new study from UVA Health has shown that tirzepatide, a drug used for weight loss and diabetes management, can lower the risk of death or worsening heart failure in patients with heart failure and obesity. Tirzepatide, developed by Eli Lilly and Co., was tested in the SUMMIT clinical trial,…
Copyright © 2023 Menhealthdomain.com [ [email protected] ]